Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 20 mg - duloxetine - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 40 mg - duloxetine - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 20 mg - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd, israel - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 40 mg - duloxetine - yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui).

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd, israel - dulaglutide - solution for injection - dulaglutide 0.75 mg / 0.5 ml - dulaglutide - type 2 diabetes mellitustrulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd, israel - dulaglutide - solution for injection - dulaglutide 1.5 mg / 0.5 ml - dulaglutide - type 2 diabetes mellitustrulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications• in addition to other medicinal products for the treatment of diabetes.

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd, israel - insulin lispro - solution for injection - insulin lispro 100 units / 1 ml - insulin lispro - treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - gastro resistant capsules - duloxetine as hydrochloride 30 mg - duloxetine - duloxetine - cymbalta is indicated for the treatment of major depressive episodes.- cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy.- cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low back pain (clbp) and chronic pain due to osteoarthritis.

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - gastro resistant capsules - duloxetine as hydrochloride 60 mg - duloxetine - duloxetine - cymbalta is indicated for the treatment of major depressive episodes.- cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy.- cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain when other therapies have failed or are contra-indicated. this has been established in studies in patients with chronic low back pain (clbp) and chronic pain due to osteoarthritis.

Israeli - Kiingereza - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - lyophilic powder for concentrated infusion - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.